Navigation Links
Clinical course of subepithelial lesions
Date:2/5/2010

Although several studies pertaining to the natural history of subepithelial tumors have been published, they have been limited by small sample size and relatively short follow-up. The natural history of subepithelial lesions has not been clearly elucidated, and the appropriate management strategy for small subepithelial tumors is still controversial.

A research article to be published on January 28, 2010 in the World Journal of Gastroenterology addresses this question. The research team from South Korea reviewed the medical records of 104 159 patients who underwent upper gastrointestinal endoscopy at the Center for Health Promotion of Samsung Medical Center between 1996 and 2003.

Their results showed that of the 252 lesions, 244 (96.8%) were unchanged. And endoscopic surveillance can be an appropriate strategy for lesions < 1 cm. Further prospective, multicenter studies with long-term follow-up would help to validate these surveillance programs.


'/>"/>

Contact: Ye-Ru Wang
wjg@wjgnet.com
86-105-908-0039
World Journal of Gastroenterology
Source:Eurekalert

Page: 1

Related medicine news :

1. Pluromed Announces Completion of Enrollment in LeGoo&#8482; Cardiac Bypass Clinical Trial
2. NHLBI funds preclinical tests on devices for infants and children with congenital heart defects
3. Medpedia Launches New Clinical Trial Platform
4. Banner Health Systems Adopts Quantros Regulatory Reporting Management (RRM) to Manage Clinical Quality and Performance Data and Support Improvements in Quality of Care
5. Health Systems, Hospitals and Universities Nationwide Chose Epocrates in 2009 for Trusted Point-of-Care Clinical Information
6. European Cancer Organization supports a revision of the EU Clinical Trials Directive
7. Roche and Catalyst Resources Team to Explore RIA Healthcare Collaboration Solutions for Enhanced Clinical Diagnosis and Education
8. Sunquest Introduces the Integrated Clinical Environment Physician Portal to US Marketplace
9. HAPPYneuron Launches the First Online Professional Destination for Clinical Cognitive Training.
10. Synomics Pharma and Bioscience Laboratories Announce Partnership to Provide Topical Clinical Phase 1 Study Services
11. ePRO on Netbooks (NetPRO) - The BEST ePRO Solution for Clinical Trials in 15 Years
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/31/2016)... ... , ... Spectrum Aquatics has launched a brand new ADA pool lift, the ... the user in mind. , “Over the last two years our key customers and ... lbs lift is a necessary requirement for certain facilities with specific needs,” said Nabil ...
(Date:5/31/2016)... ... May 31, 2016 , ... TeaZa® Energy, LLC ... pouches, on World No Tobacco Day . The new flavor—Tropical TeaZa? Energy—will ... on this summer. , The new flavor is best described as a juicy, ...
(Date:5/31/2016)... , ... May 31, 2016 , ... ... marketing services firm and statement solutions provider, for the tenth consecutive year ... May 2016 issue of Advertising Age, and SourceLink ranked eighteenth in the “U.S. ...
(Date:5/30/2016)... FL (PRWEB) , ... May 30, 2016 , ... As ... means for their children and their efforts to keep their households lice free. ... across Hawaii are enacting new policies that keep kids in the classroom despite the ...
(Date:5/30/2016)... , ... May 30, 2016 , ... Another ER facility ... in Plano, located at 3960 Legacy Drive, Plano, TX and is open 24 hours ... of Commerce followed by a medical open house. The Jasper High School band entertained ...
Breaking Medicine News(10 mins):
(Date:5/30/2016)... Eye expert s ... eye examination before leaving hospital ... Moorfields Eye Hospital Dubai, the first overseas branch of the ... identified premature babies as a special concern in the region when ... retinopathy of prematurity (ROP). ROP is a potentially blinding condition that ...
(Date:5/27/2016)... , May 27, 2016 ... innovative biopharmaceutical company focused on late-stage drug development, ... Dexcel Pharma of pivotal batches required for ... Drug Administration (FDA). This follows Kitov,s announcement ... III trial successfully met its primary efficacy endpoint. ...
(Date:5/26/2016)... , May 26, 2016 ... Associated With Both Cost Savings and Overall ... plc (LSE: BTG), an international specialist healthcare company, ... at the 21st Annual Meeting of ISPOR (International ... treatment of hepatocellular carcinoma (HCC) using yttrium-90 glass ...
Breaking Medicine Technology: